J Korean Ophthalmol Soc.  2009 Sep;50(9):1295-1300. 10.3341/jkos.2009.50.9.1295.

Effectiveness for Intralesional Triamcinolne Acetonide Injections for Chalazia in Pediatric Patients

Affiliations
  • 1Department of Ophthalmology, Yeungnam university College of Medicine, Daegu, Korea. sjh@med.yu.ac.kr

Abstract

PURPOSE
To evaluate the effectiveness of intralesional triamcinolone acetonide injection for chalazia in pediatric patients. METHODS: We performed a retrospective chart review of 58 patients (70 lesions) under fifteen years of age and 40 patients (50 lesions) aged fifteen and over, who underwent intralesional triamcinolone acetonide injections and performed follow-ups for at least three months between January 2007 and October 2008. Data regarding age, sex, lesion size, location, number of injections, treatment success, surgery, and complications were evaluated. RESULTS: Cumulative treatment success of TA was 64.3% with the first injection, 82.9% with a second injection, and 88.6% with a third injection in patients under fifteen years of age. The average number of TA injections was 1.67+/-1.03 in primary chalazia and 1.48+/-0.87 in recurrent chalazia, while the cumulative treatment success until third TA injection was 89.8% in primary chalazia and 85.7% in recurrent chalazia inpatients under fifteen years old. The average number of TA injections was 1.95+/-1.18 in primary chalazia and 1.80+/-1.14 in recurrent chalazia, while the cumulative treatment success until the third TA injection was 82.5% in primary chalazia and 70.0% in recurrent chalazia in patients aged fifteen and over. No complications were noted with TA injections. CONCLUSIONS: Intralesional triamcinolone acetonide injection in chalazia is an effective and safe treatment in pediatric patients.

Keyword

Chalazion; Intralesional injection; Triamcinolone acetonide

MeSH Terms

Aged
Chalazion
Follow-Up Studies
Humans
Injections, Intralesional
Inpatients
Retrospective Studies
Triamcinolone Acetonide
Triamcinolone Acetonide

Figure

  • Figure 1. Patient with a left lower lid chalazion (A) and remission after intralesional triamcinolone acetonide injection (B). Patient with both upper lid chalazion (C) and remission after intralesional triamcinolone acetonide injection (D).


Cited by  1 articles

The Effects of Intralesional Steroid Injection for Chalazion According to the Concentrations of Triamcinolone Acetonide
Eun Joo Kim, Sung Yu, Byung Jin Jeong, Kyoo Won Lee, Hong Jae Mun
J Korean Ophthalmol Soc. 2013;54(3):396-400.    doi: 10.3341/jkos.2013.54.3.396.


Reference

References

1. Perry HD, Serniuk RA. Conservative treatment of chalazia. Ophthalmology. 1980; 87:218–21.
Article
2. Donaldson MJ, Gole GA. Amblyopia due to inflamed chalazion in a 13-month old infant. Clin Experiment Ophthalmol. 2005; 33:332–3.
3. Watson AP, Austin DJ. Treatment of chalazions with injection of a steroid suspension. Br J Ophthalmol. 1984; 68:833–5.
Article
4. Ben Simon GJ, Huang L, Nakra T, et al. Intralesional triamcinolone acetonide injection for primary and recurrent chalazia: is it really effective? Ophthalmology. 2005; 112:913–7.
Article
5. Goawalla A, Lee V. A prospective randomized treatment study comparing three treatment options for chalazia: triamcinolone acetonide injections, incision and curettage and treatment with hot compresses. Clin Experiment Ophthalmol. 2007; 35:706–12.
Article
6. Korn EL. Laser chalazion removal. Ophthalmic Surg. 1988; 19:428–31.
Article
7. Prasad S, Gupta AK. Subconjunctival total excision in the treatment of chronic chalazia. Indian J Ophthalmol. 1992; 40:103–5.
8. Dua HS, Nilawar DV. Nonsurgical therapy of chalazion. Am J Ophthalmol. 1982; 94:424–5.
9. Pizzarello LD, Jakobiec FA, Hofeldt AJ, et al. Intralesional corticosteroid therapy of chalazia. Am J Ophthalmol. 1978; 85:818–21.
Article
10. Castrén J, Stenborg T. Corticosteroid injection of chalazia. Acta Ophthalmol (Copenh). 1983; 61:938–42.
11. Mohan K, Dhir SP, Munjal VP, Jain IS. The use of intralesional steroids in the treatment of chalazion. Ann Ophthalmol. 1986; 18:158–60.
12. Smythe D, Hurwitz JJ, Tayfour F. The management of chalazion; a survey of Ontario ophthalmologists. Can J Ophthalmol. 1990; 25:252–5.
13. Kim YW, Lee JO, Lee HB. Intralesional triamcinolone acetonide therapy of chalzia. J Korean Ophthalmol Soc. 1980; 21:377–9.
14. Park YG, Park YT, Hong KS. Intralesional triamcinolone acetonide therapy of chalzia. J Korean Ophthalmol Soc. 1981; 22:499–502.
15. Mustafa TA, Oriafage IH. Three methods of treatment of chalazia in children. Saudi Med J. 2001; 22:968–72.
16. Thomas EL, Laborde RP. Retinal and choroidal vascular occlusion following intralesional corticosteroid injection of a chalazion. Ophthalmology. 1986; 93:405–7.
Article
17. Cohen BZ, Tripathi RC. Eyelid depigmentation after intralesional injection of a fluorinated corticosteroid for chalazion. Am J Ophthalmol. 1979; 88:269–70.
Article
18. Hosal BM, Zilelioglu G. Ocular complication of intralesional corticosteroid injection of a chalazion. Eur J Ophthalmol. 2003; 13:798–9.
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr